Overview
News
Technologies
Salaries
Products
People
Growth
Financials

Overview

Alivas develops a first-in-the-world, minimally invasive medical device that offers a one-time treatment for patients with refractory constipation. The company originated from the Japan Biodesign fellowship and participates in Japan's METI J-Startup program to advance clinical translation of its technology. Its target market is patients with chronic refractory constipation and the broader gastroenterology medical device sector in Japan and international markets.